VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01873 VIVA BIOTECH

Closed 12-17 16:08:10

1.860

+0.000

0.00%

High1.880	Low1.830	Vol2.18M
Open1.860	D1 Closing1.860	Amplitude2.69%
Mkt Cap3.96B	Tradable Cap3.96B	Total Shares2.13B
T/O4.05M	T/O Rate0.10%	Tradable Shares2.13B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01873","market":"HK","secType":"STK","nameCN":"VIVA BIOTECH","latestPrice":1.86,"timestamp":1765958890005,"preClose":1.86,"halted":0,"volume":2183016,"delay":0,"floatShares":2130000000,"shares":2130000000,"eps":0.0939074826121458,"marketStatus":"Closed","change":0,"latestTime":"12-17 16:08:10","open":1.86,"high":1.88,"low":1.83,"amount":4054018,"amplitude":0.026882,"askPrice":1.86,"askSize":5000,"bidPrice":1.85,"bidSize":68000,"shortable":3,"etf":0,"ttmEps":0.09832665826448207,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"listingDate":1557331200000,"exchange":"SEHK","adjPreClose":1.86,"openAndCloseTimeList":[[1765935000000,1765944000000],[1765947600000,1765958400000]],"volumeRatio":0.429744,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01873/wiki","defaultTab":"wiki","newsList":[{"id":"1165182041","title":"$40 Million Investment Gain Fails to Prevent Intraday 15% Plunge: What's VIVA BIOTECH (01873) Worth Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1165182041","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165182041?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:30","pubTimestamp":1765801837,"startTime":"0","endTime":"0","summary":"On the evening of December 14, VIVA BIOTECH (01873) announced that Swedish Orphan Biovitrum AB (\"Sobi\") had entered into an acquisition agreement with Arthrosi, a company incubated through VIVA...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"2591690511","title":"VIVA Biotech's Invested and Incubated Company, Arthrosi, Has Entered Into an Acquisition Agreement With Sobi for a Total Transaction Value of up to US$1.5 Billion.","url":"https://stock-news.laohu8.com/highlight/detail?id=2591690511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591690511?lang=en_us&edition=fundamental","pubTime":"2025-12-15 14:06","pubTimestamp":1765778786,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA8MB7VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"1137751292","title":"Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 13% as Investee Arthrosi Reaches Acquisition Deal with Sobi","url":"https://stock-news.laohu8.com/highlight/detail?id=1137751292","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137751292?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:38","pubTimestamp":1765762695,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) rose more than 13%, reaching HK$2.2 by the time of writing, with a turnover of HK$4.82 million. The surge follows news on December 13 that Swedish Orphan Biovitrum AB (Sobi), a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"1166210762","title":"VIVA BIOTECH (01873) Divests Stake in an Investment Incubator Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1166210762","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166210762?lang=en_us&edition=fundamental","pubTime":"2025-12-14 19:22","pubTimestamp":1765711334,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that Arthrosi Therapeutics has informed the company that on December 13, 2025, the buyer, Sobi US Holding Corp., agreed to acquire Arthrosi Therapeutics through a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2591366366","title":"VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2591366366","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591366366?lang=en_us&edition=fundamental","pubTime":"2025-12-14 19:11","pubTimestamp":1765710718,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings announced that its wholly-owned subsidiary, Viva Incubator, has agreed to dispose of its minority equity interest in Arthrosi Therapeutics. The transaction will occur through a merger in which Sobi US Holding Corp. will acquire Arthrosi Therapeutics. Under the terms of the merger agreement, Viva Biotech Holdings will receive an upfront payment of US$950 million at closing, subject to customary adjustments, and may receive additional contingent consideration of up to US$550 million. Following the completion of the merger, Viva Biotech Holdings will no longer hold any equity interest in Arthrosi Therapeutics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nNDL2GSY3t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"1166395462","title":"Viva Biotech Holdings (1873) Announces Grant of 8.58 Million Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1166395462","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166395462?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:24","pubTimestamp":1764674652,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings (1873) issued an announcement on December 2, 2025, regarding the grant of 8,580,000 share options to employees under its Post-IPO Share Option Scheme. The exercise price was set...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"gpt_icon":0},{"id":"1121881798","title":"VIVA BIOTECH (01873) Grants 8.58 Million Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1121881798","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121881798?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:12","pubTimestamp":1764673931,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that the company has granted share options to certain eligible participants on December 2, 2025, under its share option scheme adopted on April 14, 2019. The options allow the subscription of a total of 8.58 million ordinary shares of the company.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"1150686106","title":"Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150686106","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150686106?lang=en_us&edition=fundamental","pubTime":"2025-11-21 14:52","pubTimestamp":1763707934,"startTime":"0","endTime":"0","summary":"CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK0216","BK1576","HK0000306701.USD","01548","HK0000306685.HKD","300759","01873","HK0000320264.USD","BK1141","HK0000320223.HKD","03759","03347"],"gpt_icon":0},{"id":"1158911208","title":"Viva Biotech Holdings (01873) Announces Monthly Return on Share Capital Movements for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1158911208","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158911208?lang=en_us&edition=fundamental","pubTime":"2025-11-05 15:21","pubTimestamp":1762327310,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings reported no change in its authorized share capital, which remains at 4,000,000,000 ordinary shares with a par value of USD 0.000025 each, totaling USD 100,000. The number of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"gpt_icon":0},{"id":"2577759947","title":"Individual investors among Viva Biotech Holdings' (HKG:1873) largest stockholders and were hit after last week's 7.3% price drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2577759947","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577759947?lang=en_us&edition=fundamental","pubTime":"2025-10-24 11:07","pubTimestamp":1761275272,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by individual investors in Viva Biotech Holdings indicates that they...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/individual-investors-among-viva-biotech-holdings-hkg1873-lar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/individual-investors-among-viva-biotech-holdings-hkg1873-lar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01873","BK4121","BK1141","VBIZF","BK1576"],"gpt_icon":0},{"id":"1120022384","title":"Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=1120022384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120022384?lang=en_us&edition=fundamental","pubTime":"2025-10-14 14:30","pubTimestamp":1760423428,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks have continued their sluggish performance over consecutive days, with declines expanding further in the afternoon session. As of press time, VIVA BIOTECH (01873) dropped 7.53%...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1583","BK1141","02162","01672","09939","159938","LU0196878994.USD","BK1576","BK1587","01873","BK1515","06990"],"gpt_icon":0},{"id":"1188508612","title":"Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 10% in Afternoon Trading as AI Pharmaceutical Business Model Shows Validation, Company Takes Forward-Looking Approach in AI Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1188508612","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188508612?lang=en_us&edition=fundamental","pubTime":"2025-10-08 14:06","pubTimestamp":1759903578,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) surged over 10% in afternoon trading. As of press time, the stock rose 10.45% to HK$3.17, with trading volume reaching HK$32.0142 million. On the news front, multiple new AI...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","HSCEI","01873","BK1576","BK1574","BK1191","BK1141","BK4614","07226","YANG"],"gpt_icon":1},{"id":"2571704383","title":"VIVA Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2571704383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571704383?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:03","pubTimestamp":1759136584,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA99QCNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"1104809989","title":"Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Over 5% Again as AIDD Industry Accelerates, Company Leads AI Pharmaceutical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1104809989","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104809989?lang=en_us&edition=fundamental","pubTime":"2025-09-25 14:42","pubTimestamp":1758782543,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) continued its upward momentum with gains exceeding 5%. As of press time, the stock was up 4.44% to HK$2.59, with trading volume reaching HK$20.26 million. Guangfa Securities...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","07226","01873","BK4614","BK1576","BK1574","HSCEI","YANG","01477","BK1191"],"gpt_icon":1},{"id":"1172271876","title":"VIVA BIOTECH (01873) Receives Initial \"Buy\" Rating as CDMO and Incubation Ecosystem Synergy Opens Growth Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1172271876","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172271876?lang=en_us&edition=fundamental","pubTime":"2025-09-10 10:18","pubTimestamp":1757470713,"startTime":"0","endTime":"0","summary":"A research report has been published providing initial coverage of VIVA BIOTECH (01873) with a \"buy\" rating. The report projects net profits attributable to shareholders of 221 million yuan, 264...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","BK1576","CDMO","BK4139","BK1141","01873"],"gpt_icon":0},{"id":"1144080802","title":"Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Nearly 7% in Afternoon Session as First-Half Gross Margin Improves Significantly with Company's Forward-Looking AI Drug Development Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1144080802","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144080802?lang=en_us&edition=fundamental","pubTime":"2025-09-03 14:28","pubTimestamp":1756880898,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) jumped nearly 7% in afternoon trading, rising 6.42% to HK$2.82 with trading volume reaching HK$34.55 million as of press time. On the news front, VIVA BIOTECH recently released...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","BK1191","BK1574","BK1141","01477"],"gpt_icon":0},{"id":"2564870024","title":"Viva Biotech Unveils Breakthrough in Cyclic Peptide Therapeutics, Paving the Way for Drug Discovery Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2564870024","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564870024?lang=en_us&edition=fundamental","pubTime":"2025-09-02 17:30","pubTimestamp":1756805454,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings has announced significant advancements in the field of cyclic peptide therapeutics, emphasizing their potential to bridge the gap between small molecules and large biologics. The company's integrated platform for peptide drug discovery and development, which spans from hit discovery to preclinical candidates, has delivered over 82,000 protein structures and synthesized more than 3,000 peptides, with a focus on cyclic peptides. These advancements have already been presented, highlighting the use of AI-enabled peptide design, DEL screening, and phage display in the discovery process. With an emphasis on cyclic peptides' ability to target traditionally \"undruggable\" protein-protein interactions, Viva Biotech aims to continue collaborating with global partners to translate these innovations into real-world therapeutics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL55j28n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"1113693073","title":"Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 20% After Earnings Release, Interim Shareholder Profit Up 4.28% YoY, AI Orders Show Growing Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1113693073","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113693073?lang=en_us&edition=fundamental","pubTime":"2025-08-29 11:46","pubTimestamp":1756439183,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) surged over 20% following its earnings announcement. As of press time, the stock rose 22.32% to HK$2.85, with trading volume reaching HK$49.03 million. On August 28, VIVA BIOTECH...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"1175736006","title":"Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Pharma Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1175736006","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175736006?lang=en_us&edition=fundamental","pubTime":"2025-08-29 10:12","pubTimestamp":1756433575,"startTime":"0","endTime":"0","summary":"Viva Biotech (01873.HK) saw its stock price soar by 5.15% in Friday's trading session, as investors react positively to the accelerating commercialization of AI-driven drug development in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01873"],"gpt_icon":0},{"id":"1100107913","title":"Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Tech Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1100107913","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100107913?lang=en_us&edition=fundamental","pubTime":"2025-08-29 10:12","pubTimestamp":1756433574,"startTime":"0","endTime":"0","summary":"Viva Biotech (01873.HK) saw its stock price surge by 5.15% during Friday's trading session, as investors react positively to the company's strong positioning in the burgeoning field of AI-driven drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01873"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivabiotech.com","stockEarnings":[{"period":"1week","weight":-0.0558},{"period":"1month","weight":-0.1226},{"period":"3month","weight":-0.2677},{"period":"6month","weight":0.2157},{"period":"1year","weight":1.1136},{"period":"ytd","weight":1.1628}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0503},{"period":"3month","weight":-0.0622},{"period":"6month","weight":0.086},{"period":"1year","weight":0.2748},{"period":"ytd","weight":0.258}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.163873},{"month":2,"riseRate":0.333333,"avgChangeRate":0.044857},{"month":3,"riseRate":0.333333,"avgChangeRate":0.02465},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020806},{"month":5,"riseRate":0.666667,"avgChangeRate":0.245742},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.034299},{"month":7,"riseRate":0.714286,"avgChangeRate":0.010126},{"month":8,"riseRate":0.428571,"avgChangeRate":0.041644},{"month":9,"riseRate":0.285714,"avgChangeRate":0.021762},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.044725},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.040545},{"month":12,"riseRate":0.571429,"avgChangeRate":0.030609}],"exchange":"SEHK","name":"VIVA BIOTECH","nameEN":"VIVA BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VIVA BIOTECH,01873,VIVA BIOTECH股票,VIVA BIOTECH股票老虎,VIVA BIOTECH股票老虎国际,VIVA BIOTECH行情,VIVA BIOTECH股票行情,VIVA BIOTECH股价,VIVA BIOTECH股市,VIVA BIOTECH股票价格,VIVA BIOTECH股票交易,VIVA BIOTECH股票购买,VIVA BIOTECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}